115 related articles for article (PubMed ID: 35149583)
1. Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe.
Seidl E; Schwerk N; Carlens J; Wetzke M; Cunningham S; Emiralioğlu N; Kiper N; Lange J; Krenke K; Ullmann N; Krikovszky D; ; Maqhuzu P; Griese CA; Schwarzkopf L; Griese M
Thorax; 2022 Aug; 77(8):781-789. PubMed ID: 35149583
[TBL] [Abstract][Full Text] [Related]
2. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
3. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
4. Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016.
Moses MW; Pedroza P; Baral R; Bloom S; Brown J; Chapin A; Compton K; Eldrenkamp E; Fullman N; Mumford JE; Nandakumar V; Rosettie K; Sadat N; Shonka T; Flaxman A; Vos T; Murray CJL; Weaver MR
Lancet Public Health; 2019 Jan; 4(1):e49-e73. PubMed ID: 30551974
[TBL] [Abstract][Full Text] [Related]
5. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of varicella in Europe in the absence of universal varicella vaccination.
Pawaskar M; Méroc E; Samant S; Flem E; Bencina G; Riera-Montes M; Heininger U
BMC Public Health; 2021 Dec; 21(1):2312. PubMed ID: 34930179
[TBL] [Abstract][Full Text] [Related]
7. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
[TBL] [Abstract][Full Text] [Related]
8. A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies.
Wong AW; Koo J; Ryerson CJ; Sadatsafavi M; Chen W
BMC Pulm Med; 2022 Apr; 22(1):148. PubMed ID: 35443657
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of paediatric-onset disabilities among young and middle-aged adults in the USA: a cohort study of privately insured beneficiaries.
Whitney D; Kamdar N; Hirth RA; Hurvitz EA; Peterson MD
BMJ Open; 2019 Sep; 9(9):e030490. PubMed ID: 31481565
[TBL] [Abstract][Full Text] [Related]
10. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.
Traverso CE; Walt JG; Kelly SP; Hommer AH; Bron AM; Denis P; Nordmann JP; Renard JP; Bayer A; Grehn F; Pfeiffer N; Cedrone C; Gandolfi S; Orzalesi N; Nucci C; Rossetti L; Azuara-Blanco A; Bagnis A; Hitchings R; Salmon JF; Bricola G; Buchholz PM; Kotak SV; Katz LM; Siegartel LR; Doyle JJ
Br J Ophthalmol; 2005 Oct; 89(10):1245-9. PubMed ID: 16170109
[TBL] [Abstract][Full Text] [Related]
11. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study.
Prompers L; Huijberts M; Schaper N; Apelqvist J; Bakker K; Edmonds M; Holstein P; Jude E; Jirkovska A; Mauricio D; Piaggesi A; Reike H; Spraul M; Van Acker K; Van Baal S; Van Merode F; Uccioli L; Urbancic V; Ragnarson Tennvall G
Diabetologia; 2008 Oct; 51(10):1826-34. PubMed ID: 18648766
[TBL] [Abstract][Full Text] [Related]
12. The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study.
Wacker M; Holle R; Heinrich J; Ladwig KH; Peters A; Leidl R; Menn P
BMC Health Serv Res; 2013 Jul; 13():278. PubMed ID: 23866993
[TBL] [Abstract][Full Text] [Related]
13. Childhood interstitial lung disease due to surfactant protein C deficiency: frequent use and costs of hospital services for a single case in Australia.
Hime NJ; Fitzgerald D; Robinson P; Selvadurai H; Van Asperen P; Jaffé A; Zurynski Y
Orphanet J Rare Dis; 2014 Mar; 9():36. PubMed ID: 24642012
[TBL] [Abstract][Full Text] [Related]
14. The direct medical costs of epilepsy in children and young people: a population-based study of health resource utilisation.
Ali MA; Elliott RA; Tata LJ
Epilepsy Res; 2014 Mar; 108(3):576-86. PubMed ID: 24447611
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
Salman RA; AlSayyad AS; Ludwig C
BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
[TBL] [Abstract][Full Text] [Related]
16. Trajectories of healthcare utilization and costs of psychiatric and somatic multimorbidity in adults with childhood ADHD: a prospective register-based study.
Du Rietz E; Jangmo A; Kuja-Halkola R; Chang Z; D'Onofrio BM; Ahnemark E; Werner-Kiechle T; Larsson H
J Child Psychol Psychiatry; 2020 Sep; 61(9):959-968. PubMed ID: 32115717
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of non-malignant blood disorders across Europe: a population-based cost study.
Luengo-Fernandez R; Burns R; Leal J
Lancet Haematol; 2016 Aug; 3(8):e371-8. PubMed ID: 27476788
[TBL] [Abstract][Full Text] [Related]
18. Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country.
Thielen FW; Houwing ME; Cnossen MH; Al Hadithy-Irgiztseva IA; Hazelzet JA; Groot CAU; de Pagter APJ; Blommestein HM
Pediatr Blood Cancer; 2020 Sep; 67(9):e28588. PubMed ID: 32672889
[TBL] [Abstract][Full Text] [Related]
19. Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden.
Sejersen T; Graham S; Ekström AB; Kroksmark AK; Kwiatkowska M; Ganz ML; Justo N; Gertow K; Simpson A
Eur J Health Econ; 2024 Apr; ():. PubMed ID: 38642267
[TBL] [Abstract][Full Text] [Related]
20. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
